Zhe Jiang Dayang Biotech Group Co., Ltd. (SHE:003017)
China flag China · Delayed Price · Currency is CNY
33.09
+0.56 (1.72%)
At close: Feb 13, 2026

SHE:003017 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
Cash & Equivalents
442.83353.99382.37131.11131.8869.36
Trading Asset Securities
-40.45-296.48279.77370.08
Cash & Short-Term Investments
442.83394.44382.37427.59411.65439.44
Cash Growth
17.21%3.16%-10.58%3.87%-6.33%727.27%
Accounts Receivable
140.26127.05103.94138.96134.24147.57
Other Receivables
1.135.776.599.4518.6516.57
Receivables
141.39132.82110.54148.41152.89164.14
Inventory
115.83119.78152.23126.87161.6169.84
Prepaid Expenses
-0.310.320.350.250.25
Other Current Assets
42.7743.216.1824.9416.324.62
Total Current Assets
742.82690.55661.63728.16742.7698.29
Property, Plant & Equipment
739.39681.46671.49616.17528.02433.57
Long-Term Investments
123.03121.3954.842.52.521.91
Other Intangible Assets
89.0291.0693.3595.3656.7357.48
Long-Term Deferred Tax Assets
30.9332.3144.1745.465.544.12
Long-Term Deferred Charges
1.942.1-0.050.10.15
Other Long-Term Assets
25.6634.6721.1820.3638.7333.28
Total Assets
1,7531,6541,5471,5081,3741,229
Accounts Payable
184.06158.91189.42125.77149.16168.48
Accrued Expenses
18.2722.3821.5828.7511.359.07
Short-Term Debt
331.13358.06180.43252.11139.07-
Current Portion of Long-Term Debt
-9.51-30.03--
Current Portion of Leases
--0.87---
Current Income Taxes Payable
10.5200.07-0.151.82
Current Unearned Revenue
6.033.695.788.037.9111.92
Other Current Liabilities
55.9915.1632.133.549.539.22
Total Current Liabilities
606567.7430.26478.24317.16200.51
Long-Term Debt
13.51-69.06-39.849.87
Long-Term Leases
2.03---0.87-
Long-Term Unearned Revenue
7.859.0111.3511.969.611.25
Long-Term Deferred Tax Liabilities
21.4223.6927.7932.8116.219.04
Total Liabilities
650.82600.4538.47523.01383.64270.67
Common Stock
848484606060
Additional Paid-In Capital
545.36528.23519.47537.19563.99563.99
Retained Earnings
482.11455.2428.13413.12366.71332.7
Treasury Stock
-18.32-17.93-25.42-25.42--
Comprehensive Income & Other
4.332.662.020.160.011.44
Total Common Equity
1,0971,0521,008985.05990.71958.13
Minority Interest
4.510.99----
Shareholders' Equity
1,1021,0531,008985.05990.71958.13
Total Liabilities & Equity
1,7531,6541,5471,5081,3741,229
Total Debt
346.67367.56250.37282.14179.7449.87
Net Cash (Debt)
96.1626.87132145.45231.91389.57
Net Cash Growth
147.77%-79.64%-9.25%-37.28%-40.47%1193.42%
Net Cash Per Share
1.190.331.631.782.765.86
Filing Date Shares Outstanding
81.2683.0181.7580.088484
Total Common Shares Outstanding
81.2683.2381.280.088484
Working Capital
136.82122.85231.38249.92425.53497.78
Book Value Per Share
13.5112.6412.4212.3011.7911.41
Tangible Book Value
1,008961.1914.85889.69933.98900.65
Tangible Book Value Per Share
12.4111.5511.2711.1111.1210.72
Buildings
-338.1271.87270.86218.74190.3
Machinery
-574.75544.06569.59451.65298.26
Construction In Progress
-155.15180.8452.1584.75135.67
Source: S&P Global Market Intelligence. Standard template. Financial Sources.